April 17, 2024
Tuberculosis Vaccine Market

Tuberculosis Vaccine Market Is Emerging As A Preventive Measure To Tackle Rising TB Cases By 2030

The tuberculosis vaccine market comprises vaccines that help prevent tuberculosis (TB) disease. TB is caused by bacteria called Mycobacterium tuberculosis, which primarily affects the lungs. It spreads through air when people who have active TB in their lungs cough, sneeze or spit. The currently available TB vaccine, bacillus Calmette-Guérin (BCG), provides some protection against severe forms of TB in children. However, its effectiveness against pulmonary TB decreases with time. As a result, newer and more efficient TB vaccines are being developed.

The global tuberculosis vaccine market is estimated to be valued at US$ 172.42 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Global Tuberculosis Vaccine Market Size are Fujitsu Limited, Mindtree Limited, IBM Corporation, Wipro Limited, Unisys Corporation, CenturyLink Inc., Virtustream Inc. and HCL Technologies Limited. With rising cases of drug-resistant TB, key players are investing heavily in R&D of novel TB vaccines with higher efficacy. Growing at an annual rate of around 4.3% since 2015, the global incidence of TB reached 10 million cases in 2020. This growing disease burden along with government support in low and middle-income countries is driving the demand for advanced TB vaccines. Moreover, with support from global health organizations like WHO and GAVI, key market players are also expanding their presence across Asian and African countries to ensure broader availability of efficient TB vaccines.

The growing incidence of tuberculosis diseases worldwide is propelling the demand for advanced tuberculosis vaccines. According to the WHO, around 10 million people fell ill with tuberculosis in 2020, and 1.5 million people died due to the disease. The increasing rate of drug-resistant TB cases that cannot be treated with first-line anti-TB drugs has compelled key players to focus on development of novel vaccines. Furthermore, rising government expenditure on immunization programs in developing countries will contribute to the global expansion of the tuberculosis vaccine market during the forecast period.

Market Key Trends

One of the key trends emerging in the tuberculosis vaccine market is the rising popularity of adoptive T cell therapies. In adoptive T cell transfer approaches, T cells from TB-infected or -vaccinated individuals are isolated, expanded ex vivo, and transferred back to the same or other individuals to enhance host immunity against M. tuberculosis infection or reactivation. This approach has shown promising results in preclinical TB models. With advancements in cell processing methods, adoptive T cell therapies hold potential to become an important preventive and therapeutic strategy against drug-resistant TB in the future. This emerging area of research and development will be crucial in defining the future market outlook of tuberculosis vaccines.

Porter’s Analysis

Threat of new entrants: Vaccine development requires large capital investment and regulatory approvals which make entry difficult.

Bargaining power of buyers: National immunization programs are the major customers with significant bargaining power.

Bargaining power of suppliers: Suppliers of raw materials and contract manufacturers have less bargaining power as major companies have established relationships.

Threat of new substitutes: No substitute available currently for tuberculosis.

Competitive rivalry: Intense competition between existing players to develop better and affordable vaccines.

Geographical Regions

India has the highest TB burden in the world, accounting for around 27% of the global total. The central and eastern European region also has high rates of drug-resistant TB. South Africa and China are other major geographical regions concentrated in terms of tuberculosis vaccine value currently.

Fastest Growing Region
The African region is forecasted to be the fastest growing market for tuberculosis vaccine during the forecast period of 2024-2030. Factors such as rapid population growth, high disease prevalence, increasing healthcare investments are contributing to its growth.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it